1. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Issue 10168 (19th January 2019) Authors: Horwitz, Steven; O'Connor, Owen A; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kense... Journal: Lancet Issue: Volume 393:Issue 10168(2019) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Issue 8 (2nd July 2020) Authors: Sawas, Ahmed; Ma, Helen; Shustov, Andrei; Hsu, Pamela; Bhat, Gajanan; Acosta, Mark; Horwitz, Steven; O'Connor, Owen A. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 2003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma. Issue 8 (2nd July 2020) Authors: Sawas, Ahmed; Ma, Helen; Shustov, Andrei; Hsu, Pamela; Bhat, Gajanan; Acosta, Mark; Horwitz, Steven; O'Connor, Owen A. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 2003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. Issue 8 (August 2021) Authors: Lynch, Ryan C; Cassaday, Ryan D; Smith, Stephen D; Fromm, Jonathan R; Cowan, Andrew J; Warren, Edus H; Shadman, Mazyar S; Shustov, Andrei; Till, Brian G; Ujjani, Chaitra S; Libby, Edward N; Philip, Mary; Coye, Hilary; Martino, Christen N; Bhark, Sandra L; Morris, Karolyn; Rasmussen, Heather; Behn... Journal: Lancet Issue: Volume 8:Issue 8(2021) Page Start: e562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Kikuchi–Fujimoto Disease Associated With Subcutaneous Panniculitis-Like T-Cell Lymphoma. (June 2016) Authors: Notaro, Eliza; Shustov, Andrei; Chen, Xueyan; Shinohara, Michi M. Journal: American journal of dermatopathology Issue: Volume 38:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Issue 9 (September 2018) Authors: Kim, Youn H; Bagot, Martine; Pinter-Brown, Lauren; Rook, Alain H; Porcu, Pierluigi; Horwitz, Steven M; Whittaker, Sean; Tokura, Yoshiki; Vermeer, Maarten; Zinzani, Pier Luigi; Sokol, Lubomir; Morris, Stephen; Kim, Ellen J; Ortiz-Romero, Pablo L; Eradat, Herbert; Scarisbrick, Julia; Tsianakas, Ath... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel therapies for peripheral T-cell lymphomas. (June 2013) Authors: Shustov, Andrei Journal: Therapeutic advances in hematology Issue: Volume 4:Number 3(2013) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy. (6th February 2020) Authors: Smith, Stephen D.; Till, Brian G.; Shadman, Mazyar S.; Lynch, Ryan C.; Cowan, Andrew J.; Wu, Qian V.; Voutsinas, Jenna; Rasmussen, Heather A.; Blue, Katherine; Ujjani, Chaitra S.; Shustov, Andrei; Cassaday, Ryan D.; Fromm, Jonathan R.; Gopal, Ajay K. Journal: British journal of haematology Issue: Volume 189:Number 6(2020) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network. (19th April 2018) Authors: Federico, Massimo; Bellei, Monica; Marcheselli, Luigi; Schwartz, Marc; Manni, Martina; Tarantino, Vittoria; Pileri, Stefano; Ko, Young‐Hyeh; Cabrera, Maria E.; Horwitz, Steven; Kim, Won S.; Shustov, Andrei; Foss, Francine M.; Nagler, Arnon; Carson, Kenneth; Pinter‐Brown, Lauren C.; Montoto, Silvi... Journal: British journal of haematology Issue: Volume 181:Number 6(2018) Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials. Issue 10 (3rd October 2017) Authors: Shustov, Andrei; Coiffier, Bertrand; Horwitz, Steven; Sokol, Lubomir; Pro, Barbara; Wolfson, Julie; Balser, Barbara; Eisch, Robin; Popplewell, Leslie; Prince, H. Miles; Allen, Steven L.; Piekarz, Richard; Bates, Susan Journal: Leukemia & lymphoma Issue: Volume 58:Issue 10(2017) Page Start: 2335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗